Weight Loss

You will first complete a detailed intake process which allows us to gather information about your health history, health concerns, medications, and more.  After completing the intake process, a Lemonaid Health affiliated healthcare provider will review and conduct a consultation to determine if a weight loss treatment is appropriate for you. If suitable, your provider will discuss medication options and recommend a personalized treatment plan.

Typically, treatment begins with a lower dose to minimize side effects, gradually increasing over time until achieving a maintenance dosage. If a Lemonaid Health affiliated healthcare provider determines that weight loss treatment is appropriate for you, the provider will establish the appropriate dosing schedule for you.

As you increase your dosage you will have check-ins with a Lemonaid Health affiliated provider to discuss the appropriateness of a dosage change. Once you reach a maintenance dosage, you will have regular interval check-ins to discuss your treatment and the appropriateness of new prescriptions.

We currently offer: 

• Monthly option: $49 per month for ongoing treatment support. Please note that all medications on this option are billed separately and are not included in the membership cost.

Your membership begins when your prescription is sent to the dispensing pharmacy, which occurs after your eligibility consultation and if treatment is deemed appropriate.

The cost of your medication will depend on the membership term and the prescribed medication. Monthly membership terms are $49/month.

For compounded tirzepatide:

• Monthly: $299 per month (billed separately)

For compounded tirzepatide microdoses: 

• Monthly: $199 per month (billed separately)

For compounded semaglutide: 

• Monthly: $299 per month (billed separately)

Other medications, such as Metformin ($90/ 3 months), Ozempic® ($1,199/month) and Wegovy® ($1,599/month), are also billed separately and are not included in the membership plans.

Zepbound single-dose vials are offered via LillyDirect and are available as a cash pay-only offering starting at $299/mo for the 2.5 mg dose. LillyDirect has the ability to change the price. Unlike our other weight loss medication options we offer, Zepbound single-dose vials are delivered, charged, and managed separately via LillyDirect.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Novo Nordisk is a registered trademark of Novo Nordisk A/S. Zepbound™ is a registered trademark of Eli Lilly and Company.

Our weight loss offering is cash-pay only, so you’ll need to pay out of pocket. Lemonaid Health cannot accept insurance for membership fees, medication costs, or medical fees.

If you have a FSA or HSA, your membership fees and medications may be eligible for reimbursement. Many HSA/FSA cards can be used at checkout.*

*Check with your FSA/HSA administrator or a tax professional for confirmation on the specific requirements for individual eligibility and reimbursement, including usage, procedures and qualifications.

A Lemonaid Health affiliated healthcare provider will review your health history, weight loss goals, and various other data points to see if you qualify for treatment. Some exclusion criteria includes: 

• Patients under 18 or over 75
• Certain medical conditions may make it unsafe to take GLP-1 medication including but not limited to:
  • A personal and/or family history of medullary thyroid carcinoma and/or personal diagnosis of multiple endocrine neoplasia type 2 (MEN2)
  • Type 1 Diabetes
  • Past or current pancreatic cancer
  • Past or current pancreatitis
  • Past or current bowel obstruction, gastroparesis or ileus
  • Current cancer treatment
  • Current suicidal thoughts or ideations

• Some other medical conditions may make it unsafe to treat you online and our medical team will recommend you see a health care provider in person.

Yes, one lab order per year is included in the cost of the membership. This lab test can be fulfilled at a Quest location and is part of your weight loss membership. It evaluates various metabolism biomarkers to understand how your body is functioning.

Quest labs are located in most states, however lab testing is not yet available to customers in NY, NJ, RI, or HI.

GLP-1 medications may cause side effects including nausea, vomiting, diarrhea, constipation, and abdominal pain. Less common side effects include headache, fatigue, and dizziness. In rare cases, more serious side effects such as pancreatitis, kidney problems, bowel obstruction, or allergic reactions can occur. 

Always discuss potential side effects with a healthcare provider.

Link to Safety Information Page

During the intake process, you will schedule a consultation call with a Lemonaid Health affiliated healthcare provider to discuss the appropriateness of weight loss medication.    

During prescription renewal visits, you will have the opportunity to discuss your treatment with your provider. Additionally, you can message your provider with any clinical questions related to your treatment plan.

If you need to get in touch about non-urgent side effects, you can use the secure messaging on the Lemonaid Health platform or by calling 888-536-2267 during our business hours. For emergencies, call 911.

Weight loss injections, such as those containing GLP-1 agonists, work by mimicking the hormone GLP-1, which helps regulate appetite and blood sugar levels. These injections slow gastric emptying and increase feelings of fullness, potentially leading to weight loss.

The rate and amount of weight loss varies depending on the individual’s starting weight, adherence to the program, and specific medications used. On average, patients on GLP-1 medication can lose 15%-20% of their body weight in a year.* It is important to remember that results and timelines can vary.

New England Journal Of Medicine

*In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, those on semaglutide lost on average 14.9% of their weight as opposed to 2% of the placebo group. Both groups followed a reduced-calorie diet, increased physical activity, and monthly nutritional counseling. Starting semaglutide (Wegovy®) dosage was 0.25mg per week, increasing to 2.4mg. The trial was overseen and sponsored by Novo Nordisk.

New England Journal of Medicine

*In a 72-week placebo-controlled study of 2,539 obese and overweight non-diabetic adults with weight-related conditions, those on the highest dose of tirzepatide lost on average roughly 20% of their weight as opposed to 3.1% of the placebo group. Both groups followed healthy lifestyle changes. Starting tirzepatide dosage was 2.5mg per week, increasing to 10mg. The trial was overseen and sponsored by Eli Lilly.

Persons who stop taking GLP-1 medication may gain back any weight they lost. While these medications  assist with weight loss, the cornerstone of treatment is comprehensive lifestyle interventions. These include diet, exercise and behavioral modification to develop healthy habits that promote losing weight. Being consistent and patient is crucial; small changes can make a large impact over time. Regular self monitoring of food intake, exercise, and weight may also help you achieve and maintain your goals.  

We believe in you and your capability to make these changes. We can offer guidance, direction, and advice, and we’re here to support you along the way. We encourage you to consider a comprehensive lifestyle intervention program such as the Diabetes Prevention Program. Such programs may include behavioral self-management training, individual case managers, group and/or individual sessions, individualized adherence strategies, and a network of training, feedback, and clinical support. You can search for programs in your area by entering your zip code.

Compounding is the process of creating a customized medication to meet the specific needs of a patient. Compounding allows a pharmacy to prepare personalized medications to fit the clinical needs of an individual patient. 

Lemonaid Health works with state-licensed compounding pharmacies to offer compounded tirzepatide.

Lemonaid Health offers access to compounded tirzepatide through a partner pharmacy.  The compounded tirzepatide is made in a State Board of Pharmacy licensed sterile compounding pharmacy and provided by an FDA-inspected 503(b) outsourcing facility. Our compounded tirzepatide offering is the base form of tirzepatide.

Compounded tirzepatide is administered by subcutaneous injection. You will receive instructions on how to administer the medication. It is important to follow the dosing schedule and instructions provided to achieve the best results and minimize side effects. Injection should only occur 1 time per week. Dosage schedules at different frequencies are against safety recommendations.

The dosing varies based on individual patient needs and medical guidance. Typically, treatment begins with a lower dose to minimize side effects, with gradual increases over time. If you receive a prescription for compounded tirzepatide, a healthcare provider will determine the appropriate dosing schedule for you.

Under a clinical-guidance weight loss plan, patients will use lower doses of GLP-1/GIP medication to lose weight while helping to minimize the likelihood of side effects.

Microdosing is often chosen to reduce the risk of bothersome side effects like nausea. You will have access to health care providers who will help you monitor your progress with this personalized dose titration focused on your individualized weight loss goals and tolerability-first approach.

Lemonaid Health offers access to compounded tirzepatide through a partner pharmacy.  The compounded tirzepatide is made in a State Board of Pharmacy licensed sterile compounding pharmacy and provided by an FDA-inspected 503(b) outsourcing facility. Our compounded tirzepatide offering is the base form of tirzepatide. 

Microdoing is a tolerability-first approach to reach your goals on smaller dosages. In combination with a healthcare provider the goal is to find an effective dosage instead of simply the maximum possible dosage.

Standard GLP-1 prescriptions follow a "one-size-fits-all" schedule. Increasing your dosage from a standard dosage until a maximum maintenance dosage. Lemonaid Health’s microdosing uses smaller doses that are capped at 25% of the standard maintenance dose. This allows for a gradual, customized pace that aims to achieve weight loss goals while minimizing side effects.

Compounding is the process of creating a customized medication to meet the specific needs of a patient. Compounded medications can also be made when FDA-approved drugs are in shortage. 

Lemonaid Health works with state-licensed compounding pharmacies to offer compounded semaglutide. This medication uses the same active ingredient as Ozempic® and Wegovy®.

Lemonaid Health offers access to compounded semaglutide, made in State Board of Pharmacy licensed sterile compounding pharmacies that are FDA-inspected 503(b) outsourcing facilities. Our compounded semaglutide offering is the base form of semaglutide (same active ingredient as Ozempic® and Wegovy®) - not the sodium or acetate (“salt”) versions. 

While facilities making compounded medications are strictly regulated for certain quality practices, the compounded medications themselves are not approved or evaluated by the FDA for safety, effectiveness, or quality.

Lemonaid Health offers access to compounded semaglutide, made in State Board of Pharmacy licensed sterile compounding pharmacies in the United States that are FDA-inspected 503(b) outsourcing facilities. Both the FDA and state boards of pharmacy share responsibility in regulating aspects of compounding. Licensed compounding pharmacies must comply with both federal and state laws, including administrative requirements and quality standards.

Compounded semaglutide is administered via subcutaneous injection. Your healthcare provider will instruct you on how to properly inject the medication. It is important to follow the dosing schedule and instructions provided to achieve the best results and minimize side effects. Injection should only occur 1 time per week. Dosage schedules at different frequencies are against safety recommendations.

The dosing for compounded semaglutide varies based on individual patient needs and medical guidance. Typically, treatment begins with a lower dose to minimize side effects, with gradual increases over time. If you receive a prescription for compounded semaglutide, a healthcare provider will determine the appropriate dosing schedule for you.

Zepbound is the brand name for tirzepatide. It's an FDA-approved, once-weekly injectable medication that functions by mimicking two hormones—GLP-1 and GIP—to reduce appetite.

While all three medications are GLP-1 agonists, there are key differences:​

Active Ingredients: Zepbound contains tirzepatide, a dual agonist that targets both GIP and GLP-1 receptors. Ozempic and Wegovy contain semaglutide, which targets only the GLP-1 receptor.

FDA Approval: Zepbound and Wegovy are approved specifically for weight loss. Ozempic is approved for type 2 diabetes but is often used off-label for weight loss.

If suitable, your provider will discuss medication options and recommend a personalized treatment plan — one of those options is Zepbound vials, which would be fulfilled through LillyDirect. The medication will be delivered, charged, and managed separately via LillyDirect.

Zepbound single-dose vials offered via LillyDirect, which are available as a cash pay-only offering start at $349/mo for the 2.5 mg dose. Medication will be delivered, charged, and managed separately via LillyDirect.

These medication costs are separate from your Weight Loss Service Membership.

Metformin is an oral prescription medication most commonly used to treat type 2 diabetes. While not FDA-approved for weight loss, a licensed healthcare provider may determine it's appropriate to be sometimes prescribed off-label to support weight management, particularly in individuals with insulin resistance, prediabetes, or polycystic ovary syndrome (PCOS).